Despite lower price of generic imatinib, overall costs for chronic myeloid leukemia remain high
Despite lower price of generic imatinib, overall costs for chronic myeloid leukemia remain high ORLANDO ? The price of generic imatinib has decreased substantially in the United States over the past 2 years, according to a speaker at ASH Annual Meeting and Exposition. The decline comes after steep increases in…
Another Record Year for Generic Drug Approvals {Taj Life Sciences}: [Generic Competition]
![Another Record Year for Generic Drug Approvals {Taj Life Sciences}: [Generic Competition]](https://tajlifesciences.com/wp-content/uploads/2019/12/Another-Record-Year-for-Generic-Drug-Approvals-Taj-Pharmaceuticals-Generic-Competition-taj.jpg)
Another Record Year for Generic Drug Approvals {Taj Life Sciences}: [Generic Competition] For each of the last five years, the US Food and Drug Administration (FDA) has set generic drug approval records, but questions have lingered on whether these high approval numbers are translating into competition. FY 2019 figures show…